PLRX
PLIANT THERAPEUTICS, INC.
+0.05 (+4.67%)1.12USD194K成交股數69.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | 01-22 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 24.0K | 1.28 | 31K | 297K | SEC |
| 2026-01-20 | 01-22 | Cheung Lily | Chief Human Resource Officer | S 公開市場賣出(10b5-1) | 7.5K | 1.28 | 10K | 44.8K | SEC |
| 2026-01-20 | 01-22 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 89.4K | 1.28 | 114K | 506K | SEC |
| 2026-01-20 | 01-22 | Kuo Minnie | Chief Operating Officer | S 公開市場賣出(10b5-1) | 6.9K | 1.28 | 9K | 37.8K | SEC |
| 2025-01-23 | 01-27 | Lefebvre Eric | Chief Medical Officer | A 獲配股票 | 45.6K | – | – | 240K | SEC |
| 2025-01-23 | 01-27 | Cummings Keith Lamont | Chief Financial Officer | A 獲配股票 | 56.6K | – | – | 319K | SEC |
| 2025-01-23 | 01-27 | Hull Hans | Chief Business Officer | A 獲配股票 | 40.1K | – | – | 252K | SEC |
| 2025-01-23 | 01-27 | Ouimette Mike | General Counsel & Corp. Sec'y | A 獲配股票 | 35.0K | – | – | 106K | SEC |
| 2025-01-23 | 01-27 | Coulie Bernard | President and CEO | A 獲配股票 | 163K | – | – | 593K | SEC |
| 2025-01-23 | 01-27 | Cheung Lily | Chief Human Resource Officer | A 獲配股票 | 25.9K | – | – | 50.4K | SEC |
| 2025-01-22 | 01-22 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 10.2K | 10.99 | 112K | 70.5K | SEC |
| 2025-01-17 | 01-22 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 15.9K | 11.20 | 178K | 212K | SEC |
| 2025-01-17 | 01-22 | Cheung Lily | Chief Human Resource Officer | S 公開市場賣出(10b5-1) | 3.7K | 11.20 | 42K | 24.6K | SEC |
| 2025-01-17 | 01-22 | Lefebvre Eric | Chief Medical Officer | S 公開市場賣出(10b5-1) | 18.5K | 11.20 | 207K | 195K | SEC |
| 2025-01-17 | 01-22 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 20.1K | 11.20 | 226K | 263K | SEC |
| 2025-01-17 | 01-22 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 52.4K | 11.20 | 587K | 431K | SEC |
| 2025-01-17 | 01-22 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 13.3K | 11.20 | 149K | 80.8K | SEC |
| 2024-07-10 | 07-12 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 10.9K | 11.56 | 126K | 282K | SEC |
| 2024-07-10 | 07-12 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 38.7K | 11.56 | 447K | 483K | SEC |
| 2024-07-10 | 07-12 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 7.7K | 11.56 | 89K | 94.0K | SEC |
| 2024-07-10 | 07-12 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 9.9K | 11.56 | 114K | 227K | SEC |
| 2024-07-10 | 07-12 | Lefebvre Eric | Chief Medical Officer | S 公開市場賣出(10b5-1) | 12.3K | 11.56 | 142K | 213K | SEC |
| 2024-07-09 | 07-11 | Ouimette Mike | General Counsel & Corp. Sec'y | A 獲配股票 | 15.0K | – | – | 102K | SEC |
| 2024-07-09 | 07-11 | Lefebvre Eric | Chief Medical Officer | A 獲配股票 | 24.1K | – | – | 225K | SEC |
| 2024-07-09 | 07-11 | Hull Hans | Chief Business Officer | A 獲配股票 | 19.3K | – | – | 237K | SEC |
| 2024-07-09 | 07-11 | Coulie Bernard | President and CEO | A 獲配股票 | 75.6K | – | – | 522K | SEC |
| 2024-07-09 | 07-11 | Cummings Keith Lamont | Chief Financial Officer | A 獲配股票 | 21.3K | – | – | 293K | SEC |
| 2024-05-02 | 05-06 | Cummings Keith Lamont | Chief Financial Officer | M 選擇權執行 | 21.0K | 2.08 | 44K | 272K | SEC |
| 2024-01-23 | 01-24 | Cummings Keith Lamont | Chief Financial Officer | A 獲配股票 | 55.3K | – | – | 250K | SEC |
| 2024-01-23 | 01-24 | Cheung Lily | Chief Human Resource Officer | A 獲配股票 | 26.0K | – | – | 26.8K | SEC |
| 2024-01-23 | 01-24 | Coulie Bernard | President and CEO | A 獲配股票 | 128K | – | – | 445K | SEC |
| 2024-01-23 | 01-24 | Ouimette Mike | General Counsel & Corp. Sec'y | A 獲配股票 | 31.5K | – | – | 86.7K | SEC |
| 2024-01-23 | 01-24 | Lefebvre Eric | Chief Medical Officer | A 獲配股票 | 42.9K | – | – | 200K | SEC |
| 2024-01-23 | 01-24 | Hull Hans | Chief Business Officer | A 獲配股票 | 31.5K | – | – | 217K | SEC |
| 2024-01-17 | 01-19 | Lefebvre Eric | Chief Medical Officer | S 公開市場賣出(10b5-1) | 10.3K | 17.23 | 177K | 157K | SEC |
| 2024-01-17 | 01-19 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 5.2K | 17.23 | 90K | 55.2K | SEC |
| 2024-01-17 | 01-19 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.8K | 17.23 | 169K | 195K | SEC |
| 2024-01-17 | 01-19 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 9.8K | 17.23 | 169K | 185K | SEC |
| 2024-01-17 | 01-19 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 25.7K | 17.23 | 443K | 316K | SEC |
| 2023-08-04 | 08-07 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 20.1K | 20.01 | 401K | 195K | SEC |
| 2023-08-04 | 08-07 | Hull Hans | Chief Business Officer | M 選擇權執行 | 8.8K | 2.08 | 18K | 215K | SEC |
| 2023-08-03 | 08-07 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 1.8K | 20.00 | 36K | 206K | SEC |
| 2023-08-03 | 08-07 | Hull Hans | Chief Business Officer | M 選擇權執行 | 1.8K | 2.08 | 4K | 208K | SEC |
| 2023-08-03 | 08-07 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 13.1K | 20.00 | 261K | 206K | SEC |
| 2023-07-20 | 07-21 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 4.8K | 17.55 | 83K | 60.4K | SEC |
| 2023-07-17 | 07-19 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 70.2K | 18.01 | 1.3M | 342K | SEC |
| 2023-07-17 | 07-19 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 17.9K | 18.01 | 323K | 219K | SEC |
| 2023-07-17 | 07-19 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 12.8K | 18.01 | 230K | 65.2K | SEC |
| 2023-07-17 | 07-19 | Lefebvre Eric | Chief Medical Officer | S 公開市場賣出(10b5-1) | 22.3K | 18.01 | 402K | 167K | SEC |
| 2023-07-17 | 07-19 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 19.8K | 18.01 | 356K | 204K | SEC |
| 2023-07-14 | 07-18 | Coulie Bernard | President and CEO | A 獲配股票 | 138K | – | – | 412K | SEC |
| 2023-07-14 | 07-18 | Cummings Keith Lamont | Chief Financial Officer | A 獲配股票 | 38.8K | – | – | 224K | SEC |
| 2023-07-14 | 07-18 | Ouimette Mike | General Counsel & Corp. Sec'y | A 獲配股票 | 27.2K | – | – | 78.0K | SEC |
| 2023-07-14 | 07-18 | Lefebvre Eric | Chief Medical Officer | A 獲配股票 | 43.8K | – | – | 190K | SEC |
| 2023-07-14 | 07-18 | Hull Hans | Chief Business Officer | A 獲配股票 | 35.2K | – | – | 237K | SEC |
| 2023-06-13 | 06-14 | Cummings Keith Lamont | Chief Financial Officer | M 選擇權執行 | 30.8K | 2.08 | 64K | 185K | SEC |
| 2023-06-09 | 06-12 | Cummings Keith Lamont | Chief Financial Officer | M 選擇權執行 | 5.8K | 2.08 | 12K | 154K | SEC |
| 2023-04-03 | 04-03 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 2.7K | 26.74 | 72K | 51.0K | SEC |
| 2023-04-03 | 04-03 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 200 | 27.46 | 5K | 50.8K | SEC |
| 2023-03-30 | 04-03 | Ouimette Mike | General Counsel & Corp. Sec'y | S 公開市場賣出(10b5-1) | 4.9K | 26.52 | 129K | 53.7K | SEC |
| 2023-03-30 | 04-03 | Lefebvre Eric | Chief Medical Officer | S 公開市場賣出(10b5-1) | 11.2K | 26.52 | 298K | 146K | SEC |
| 2023-03-30 | 04-03 | Hull Hans | Chief Business Officer | S 公開市場賣出(10b5-1) | 9.0K | 26.52 | 240K | 202K | SEC |
| 2023-03-30 | 04-03 | Cummings Keith Lamont | Chief Financial Officer | S 公開市場賣出(10b5-1) | 10.0K | 26.52 | 264K | 148K | SEC |
| 2023-03-30 | 04-03 | Coulie Bernard | President and CEO | S 公開市場賣出(10b5-1) | 35.3K | 26.52 | 937K | 275K | SEC |
| 2023-03-29 | 03-31 | Coulie Bernard | President and CEO | A 獲配股票 | 68.7K | – | – | 310K | SEC |
| 2023-03-29 | 03-31 | Ouimette Mike | General Counsel & Corp. Sec'y | A 獲配股票 | 13.6K | – | – | 58.5K | SEC |
| 2023-03-29 | 03-31 | Lefebvre Eric | Chief Medical Officer | A 獲配股票 | 21.9K | – | – | 157K | SEC |
| 2023-03-29 | 03-31 | Hull Hans | Chief Business Officer | A 獲配股票 | 17.6K | – | – | 211K | SEC |
| 2023-03-29 | 03-31 | Cummings Keith Lamont | Chief Financial Officer | A 獲配股票 | 19.4K | – | – | 158K | SEC |
| 2023-02-03 | 02-06 | Coulie Bernard | President and CEO | M 選擇權執行 | 15.0K | 6.22 | 93K | 255K | SEC |
| 2023-02-03 | 02-06 | Coulie Bernard | President and CEO | S 公開市場賣出 | 5.3K | 34.08 | 179K | 240K | SEC |
| 2023-02-03 | 02-06 | Coulie Bernard | President and CEO | S 公開市場賣出 | 9.7K | 33.36 | 325K | 245K | SEC |
| 2023-02-02 | 02-06 | Coulie Bernard | President and CEO | S 公開市場賣出 | 1.6K | 34.96 | 56K | 240K | SEC |
| 2023-02-02 | 02-06 | Coulie Bernard | President and CEO | S 公開市場賣出 | 13.4K | 34.13 | 457K | 242K | SEC |
| 2023-02-02 | 02-06 | Coulie Bernard | President and CEO | M 選擇權執行 | 15.0K | 6.22 | 93K | 255K | SEC |
| 2023-02-01 | 02-01 | Coulie Bernard | President and CEO | S 公開市場賣出 | 5.4K | 34.78 | 189K | 240K | SEC |
| 2023-02-01 | 02-01 | Coulie Bernard | President and CEO | M 選擇權執行 | 15.0K | 6.22 | 93K | 255K | SEC |
| 2023-02-01 | 02-01 | Coulie Bernard | President and CEO | S 公開市場賣出 | 9.5K | 34.15 | 323K | 246K | SEC |
| 2023-02-01 | 02-01 | Coulie Bernard | President and CEO | S 公開市場賣出 | 105 | 35.55 | 4K | 240K | SEC |
| 2023-01-31 | 02-01 | Coulie Bernard | President and CEO | M 選擇權執行 | 4.5K | 6.22 | 28K | 255K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6.1M | 7.0M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 5.5M | 6.3M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | 2.8M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 2.3M | 2.6M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 2.1M | 2.4M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 2.0M | 2.3M | 新進 | 新進 |
| Monaco Asset Management SAM | 1.9M | 2.2M | 新進 | 新進 |
| Lynx1 Capital Management LP | 1.8M | 2.0M | 新進 | 新進 |
| BML Capital Management, LLC | 1.5M | 1.8M | 新進 | 新進 |
| Prosight Management, LP | 1.4M | 1.6M | 新進 | 新進 |
| Peapod Lane Capital LLC | 1.3M | 1.5M | 新進 | 新進 |
| Woodline Partners LP | 1.3M | 1.5M | 新進 | 新進 |
| BlackRock, Inc. | 1.2M | 1.3M | 新進 | 新進 |
| Ikarian Capital, LLC | 1.0M | 1.1M | 新進 | 新進 |
| Eversept Partners, LP | 891K | 1.0M | 新進 | 新進 |
| MARSHALL WACE, LLP | 835K | 952K | 新進 | 新進 |
| Redmile Group, LLC | 772K | 880K | 新進 | 新進 |
| JPMORGAN CHASE & CO | 682K | 784K | 新進 | 新進 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 643K | 733K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 579K | 660K | 新進 | 新進 |
| UBS Group AG | 572K | 652K | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 559K | 638K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 554K | 631K | 新進 | 新進 |
| Connor, Clark & Lunn Investment Management Ltd. | 536K | 611K | 新進 | 新進 |
| DAFNA Capital Management LLC | 487K | 555K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 86 -5 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 86 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 48.1M · 77.7% |
| 合計季末市值 | 51.3M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.3M |
|---|---|
| 與上期比 | +18.4% |
| 佔流通股數 | 5.29% |
| 日均成交量 | 456K |
| 回補天數 | 7.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.3M | +18.4% | 5.29% | 456K | 7.2 |
| 2026-08-14 | 2.8M | -1.4% | 4.47% | 362K | 7.7 |
| 2026-07-31 | 2.8M | -0.5% | 4.53% | 490K | 5.7 |
| 2026-07-15 | 2.8M | +9.3% | 4.56% | 862K | 3.3 |
| 2026-06-30 | 2.6M | -8.3% | 4.17% | 368K | 7.0 |
| 2026-06-15 | 2.8M | -18.0% | 4.55% | 538K | 5.2 |
| 2026-05-29 | 3.4M | -0.3% | 5.55% | 569K | 6.0 |
| 2026-05-15 | 3.4M | +0.4% | 5.56% | 330K | 10.4 |
| 2026-04-30 | 3.4M | -5.8% | 5.54% | 644K | 5.3 |
| 2026-04-15 | 3.6M | -9.6% | 5.88% | 349K | 10.4 |
| 2026-03-31 | 4.0M | +6.0% | 6.50% | 562K | 7.2 |
| 2026-03-13 | 3.8M | +0.4% | 6.14% | 483K | 7.9 |
| 2026-02-27 | 3.8M | -8.9% | 6.11% | 777K | 4.9 |
| 2026-02-13 | 4.2M | -0.6% | 6.71% | 798K | 5.2 |
| 2026-01-30 | 4.2M | +11.5% | 6.75% | 976K | 4.3 |
| 2026-01-15 | 3.8M | +21.0% | 6.06% | 1.1M | 3.5 |
| 2025-12-31 | 3.1M | -2.6% | 5.01% | 790K | 3.9 |
| 2025-12-15 | 3.2M | -20.3% | 5.14% | 2.7M | 1.2 |
| 2025-11-28 | 4.0M | +3.7% | 6.45% | 871K | 4.6 |
| 2025-11-14 | 3.9M | +3.4% | 6.22% | 703K | 5.5 |
| 2025-10-31 | 3.7M | -2.7% | 6.01% | 1.1M | 3.4 |
| 2025-10-15 | 3.8M | +2.1% | 6.18% | 773K | 5.0 |
| 2025-09-30 | 3.7M | +0.3% | 6.06% | 371K | 10.1 |
| 2025-09-15 | 3.7M | +11.3% | 6.04% | 786K | 4.8 |
| 2025-08-29 | 3.4M | +1.2% | 5.42% | 693K | 4.9 |
| 2025-08-15 | 3.3M | +1.3% | 5.36% | 1.3M | 2.6 |